Go to home page
Ultima Genomics
Join us at ASHG

Come see how our customers are unleashing a new era in high-throughput genomics

ASHG | Los Angeles Convention Center | October 25th-29th

Be sure to arrive in time for Tuesday’s lunch symposium in Room 402AB, and visit us in Booth 2005 as leaders in genomics show how they are deploying a variety of applications on the Ultima platform, taking advantage of the lowest-cost, highest-throughput sequencing architecture.



Tuesday, October 25 | Room 402AB | Lunch 11:15, Talks 11:45-12:45

New Sequencing Technologies for Undiagnosed Diseases

Sponsored by the Department of Molecular and Human Genetics and the Undiagnosed Diseases Center at Baylor College of Medicine

Advanced genomic assays have been used in the research setting to diagnose undiagnosed disease patients. Strategies that vastly reduce the cost of sequencing will enable broader reach to underinsured and underserved populations. Another impact will be vastly increasing data density and read depth with concomitant improvement in sensitivity and throughput. This symposium brings together leaders in clinical genomic implementation and advanced genome sequencing technologies to present their efforts to translate these methods to the clinical diagnostic laboratory setting.


Brendan Lee, M.D., Ph.D. | Robert and Janice McNair Endowed Chair and Professor, Department of Molecular and Human Genetics, Baylor College of Medicine

Deep RNAseq for Undiagnosed Disease Diagnosis

Pengfei Liu, Ph.D., Assistant Professor, Department of Molecular and Human Genetics, Baylor College of Medicine

Validation for Clinical Reporting of Whole Genome Sequencing

Christine Eng, M.D., Professor and Vice Chair for Diagnostic Laboratory Affairs, Department of Molecular and Human Genetics, Baylor College of Medicine, Chief Quality Officer, Chief Medical Officer, Baylor Genetics

Novel Sequencing Technologies for WGS-based Clinical Genomics

Doron Lipson, Ph.D., CSO, Ultima Genomics


Wednesday, October 26 | 3:00 – 4:45pm

PB2902 | An evaluation of the Ultima Genomics sequencing platform: Scalable, high-throughput sequencing for low-cost whole genome sequencing
M. Coole, et. al. The Broad Institute of MIT and Harvard

PB3088 | Novel sequencing platform using an open fluidics architecture and mostly natural chemistry for cost-efficient whole genome sequencing.
D. Lipson, et. al. Ultima Genomics

Thursday, October 27 | 3:00 – 4:45pm

PB1063 | Deep and error corrected sequencing via the low-cost Ultima Genomics platform enables ultra-sensitive circulating tumor DNA cancer monitoring
A. Cheng, et. al. Weill Cornell Medical Center

PB2936 | Clinical genome and RNA sequencing with a novel, cheaper sequencing-by-synthesis technology
P. Liu, et. al. Baylor College of Medicine

PB3130 | Sentieon DNAscope: high accuracy small variant calling using machine learning
B. Gallagher.
 Sentieon Inc

Schedule a meeting with our team to find out more about what we will be unleashing at ASHG.

Request for information

Please fill out the below fields to access this document.